Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Tianjin Development Holdings ( (HK:0882) ) has issued an announcement.
Tianjin Development Holdings Limited has completed a share repurchase program and adopted a share award scheme through its subsidiary, Tianjin Lisheng Pharmaceutical Co., Ltd. Lisheng Pharmaceutical repurchased 7,209,980 ordinary shares, approximately 2.80% of its issued share capital, on the Shenzhen Stock Exchange. These shares will be used for the Share Award Scheme without issuing new shares. The adoption of the Share Award Scheme was approved at a general meeting, marking its official implementation. This move is likely to enhance shareholder value and align interests with stakeholders.
More about Tianjin Development Holdings
Tianjin Development Holdings Limited operates in the pharmaceutical industry through its subsidiary, Tianjin Lisheng Pharmaceutical Co., Ltd. The company focuses on the development, manufacturing, and marketing of pharmaceutical products.
See more data about 0882 stock on TipRanks’ Stock Analysis page.
